Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Cash from Operations: 2023-2024

Historic Cash from Operations for Camp4 Therapeutics (CAMP) over the last 2 years, with Dec 2024 value amounting to -$45.6 million.

  • Camp4 Therapeutics' Cash from Operations fell 15.72% to -$11.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$47.2 million, marking a year-over-year decrease of 2.42%. This contributed to the annual value of -$45.6 million for FY2024, which is 3.27% down from last year.
  • Per Camp4 Therapeutics' latest filing, its Cash from Operations stood at -$45.6 million for FY2024, which was down 3.27% from -$44.2 million recorded in FY2023.
  • In the past 5 years, Camp4 Therapeutics' Cash from Operations registered a high of -$44.2 million during FY2023, and its lowest value of -$45.6 million during FY2024.
  • Moreover, its 2-year median value for Cash from Operations was -$44.9 million (2023), whereas its average is -$44.9 million.
  • Data for Camp4 Therapeutics' Cash from Operations shows a maximum YoY declined of 3.27% (in 2024) over the last 5 years.
  • Over the past 2 years, Camp4 Therapeutics' Cash from Operations (Yearly) stood at -$44.2 million in 2023, then fell by 3.27% to -$45.6 million in 2024.